JP Morgan Maintains Neutral on Benefitfocus, Lowers Price Target to $11
JP Morgan analyst Pinjalim Bora maintains Benefitfocus (NASDAQ:BNFT) with a Neutral and lowers the price target from $13 to $11.
Benefitfocus: Q4 Earnings Insights
Benefitfocus (NASDAQ:BNFT) reported its Q4 earnings results on Tuesday, March 1, 2022 at 04:05 PM.
Here's what investors need to know about the announcement.
Benefitfocus Q4 EPS $0.24 Beats $0.07 Estimate, Sales $75.10M Beat $70.00M Estimate
Benefitfocus (NASDAQ:BNFT) reported quarterly earnings of $0.24 per share which beat the analyst consensus estimate of $0.07 by 242.86 percent. This is a 33.33 percent increase over earnings of $0.18 per share from the
Earnings Scheduled For November 3, 2021
Companies Reporting Before The Bell
• R.R.Donnelley & Sons (NYSE:RRD) is likely to report quarterly earnings at $0.32 per share on revenue of $1.19 billion.
Benefitfocus Reports Addition Of COVID-19 Vaccination Tracking Features to Co. Platform
Today Benefitfocus, Inc. (NASDAQ: BNFT), an industry-leading benefits technology platform that simplifies benefits administration for employers, health plans and brokers, announced the addition of COVID-19
Return on Capital Employed Insights for Benefitfocus
Pulled from Benzinga Pro data Benefitfocus (NASDAQ:BNFT) reported Q2 sales of $60.90 million. Earnings fell to a loss of $9.45 million, resulting in a 371.19% decrease from last quarter.
Benefitfocus Achieves HITRUST CSF® Certification to Enhance Third-Party Privacy, Security and Compliance for Customer Data
Benefitfocus, Inc. (NASDAQ:BNFT), an industry-leading benefits technology platform that simplifies benefits administration for employers, health plans and brokers, today announced its core benefits
Benefitfocus Q2 EPS $(0.18) Misses $(0.14) Estimate, Sales $60.90M Beat $59.16M Estimate
Benefitfocus (NASDAQ:BNFT) reported quarterly losses of $(0.18) per share which missed the analyst consensus estimate of $(0.14) by 28.57 percent. This is a 30.77 percent increase over losses of $(0.26) per share from
Earnings Scheduled For August 3, 2021
Companies Reporting Before The Bell
• Myriad Genetics (NASDAQ:MYGN) is likely to report earnings for its fourth quarter.
• Stellantis (NYSE:STLA) is expected to report earnings for its second quarter.